$BTLN

BTLN SEC Filings - Glimpse Group, Inc. 10-K, 10-Q, 8-K Forms

Glimpse Group (BTLN) faces delisting from Nasdaq for failing to meet the $1.00 minimum bid price requirement. The company plans to request a hearing to contest the delisting, but continued listing is not guaranteed. The firm provides SEC filings and analysis for investors.

Original reporting
Published Sep 11, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 7:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$BTLN
Bearish
high confidence
Mentioned
$BTLN
Relevance
6/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$BTLNBearishHigh
01

Why it matters

The delisting notice is a primary corporate action that can materially affect the stock's price and liquidity.

02

Market read

Investors should assess immediate risk of price decline and consider exiting positions or hedging.

03

What to watch

Potential for a hearing panel stay or a successful appeal that preserves listing.

Relevance 6/10Novelty 8/10Timing: today

Background

Glimpse Group (BTLN) failed to maintain a $1.00 minimum bid price for 30 consecutive days, triggering Nasdaq delisting procedures.

Company-level read

Ticker impact

$BTLNBearishHigh confidence
Context

Nasdaq staff determination to delist Glimpse Group for failing to meet the $1 minimum bid price.

Expected impact

downward pressure, possible double‑digit decline if delisting proceeds

Evidence & confidence

Delisting removes access to major market, historically triggers rapid price drops for similar micro‑caps.

Market effects

Other Nasdaq‑listed micro‑caps may face heightened scrutiny on bid‑price compliance.

Limited to U.S. equity markets; no broader regional effect.

Minimal global impact; primarily affects investors in BTLN.

Counterpoint

If the company secures a reverse split or raises capital quickly, the price could rebound.

Key entities

  • Glimpse Group, Inc.

    Subject of the delisting notice.

  • Nasdaq

    Issuer of the delisting determination.

Related articles

$NVDAMed

Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPO

Iambic Therapeutics, backed by NVIDIA (NVDA) and Qatar Investment Authority, filed for a U.S. IPO and partnered with AbbVie (ABBV) for AI-driven drug discovery. AbbVie will use Iambic's AI platform for small-molecule programs, with a $40M upfront payment and up to $670M in milestones. NVIDIA benefits from increased demand for its compute resources. AbbVie reported Q2 2026 revenue of $16.99B, with strong hedge fund interest.

$BYNDMed

Why Beyond Meat (BYND) Shares Are Getting Obliterated Today

Beyond Meat (BYND) shares fell 14.1% after agreeing to retire $15M in convertible notes by issuing 1.1M shares, with potential for more. The company will issue additional shares if the stock price remains below $7.4009 during a three-day window. The move is part of a debt cleanup but has impacted the stock price significantly.

$HSLVMedAI 8/10

Highlander lines up $330M Corani silver project debt

Highlander Silver (HSLV) plans a $330M 7-year loan for its Corani silver project in Peru, with Natixis leading. The loan includes a $100M cost-overrun provision. Highlander has $100M cash and no debt. Corani has 229M oz. silver reserves. Construction may start in 2027, with first production by 2029. Shares fell 7% on Wednesday.